BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010;56:539-549. [PMID: 20688208 DOI: 10.1016/j.jacc.2009.12.075] [Cited by in Crossref: 214] [Cited by in F6Publishing: 233] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Isaak A, Chang J, Mesropyan N, Kravchenko D, Endler C, Bischoff L, Böhling N, Pieper CC, Kuetting D, Strassburg CP, Attenberger U, Jansen C, Praktiknjo M, Luetkens JA. Cardiac involvement in non-cirrhotic portal hypertension: MRI detects myocardial fibrosis and oedema similar to compensated cirrhosis. European Heart Journal - Cardiovascular Imaging 2022. [DOI: 10.1093/ehjci/jeac235] [Reference Citation Analysis]
2 Kanwal M, Hussain W, Soomro A, Aijaz R, Khalique S, Sadaf M. Prevalence of Prolonged QT Interval In Patients With Chronic Liver Disease. PJHS 2022. [DOI: 10.54393/pjhs.v3i05.258] [Reference Citation Analysis]
3 Wu HHL, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol 2022; 28(39): 5666-5678 [DOI: 10.3748/wjg.v28.i39.5666] [Reference Citation Analysis]
4 González-mansilla A, Castellote-domínguez I, Fernández-quintanilla S, Martínez-legazpi P, Ripoll C, Vega Catalina M, Rincón D, Fernández-avilés F, Bañares R, Bermejo J. Prognostic implications of systolic function in patients with cirrhosis. Gastroenterología y Hepatología 2022. [DOI: 10.1016/j.gastrohep.2022.10.011] [Reference Citation Analysis]
5 Rajewski P, Zarębska-michaluk D, Janczewska E, Gietka A, Mazur W, Tudrujek-zdunek M, Tomasiewicz K, Belica-wdowik T, Baka-ćwierz B, Dybowska D, Halota W, Lorenc B, Sitko M, Garlicki A, Berak H, Horban A, Orłowska I, Simon K, Socha Ł, Wawrzynowicz-syczewska M, Jaroszewicz J, Deroń Z, Czauż-andrzejuk A, Citko J, Krygier R, Piekarska A, Laurans Ł, Dobracki W, Białkowska J, Tronina O, Wietlicka-piszcz M, Pawłowska M, Flisiak R. Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study. JCM 2022;11:5193. [DOI: 10.3390/jcm11175193] [Reference Citation Analysis]
6 Aboul-ezz MA, Rahim AA, El-mikkawy A, Elkady MA, Elrefaiy MA, El-shishtawy S, Mosbah O, Mabrouk K, Elshafie M, Sabry OM. Hepatorenal Syndrome: A Way for Early and Accurate Diagnosis. Open Access Maced J Med Sci 2022;10:1979-1986. [DOI: 10.3889/oamjms.2022.9675] [Reference Citation Analysis]
7 Kalluru R, Gadde S, Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri SP. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart. Cureus 2022. [DOI: 10.7759/cureus.27969] [Reference Citation Analysis]
8 González-domínguez E, Córdova D, Abad P, González E, Cordero JJ. Cardiomiopatía en el paciente con cirrosis hepática: artículo de revisión. Hepatología 2022. [DOI: 10.52784/27112330.154] [Reference Citation Analysis]
9 Gîrleanu I, Trifan A, Huiban L, Muzîca C, Petrea OC, Sîngeap AM, Cojocariu C, Chiriac S, Cuciureanu T, Costache II, Stanciu C. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury. Life (Basel) 2022;12:1036. [PMID: 35888123 DOI: 10.3390/life12071036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ben Hammouda S, Grayaa M, Njima M, Mabrouk S, Boussaid M, Aissaoui A, Zakhama A, Hadhri R. Sudden death due to cirrhotic cardiomyopathy: An autopsy case report. Journal of Forensic and Legal Medicine 2022;89:102369. [DOI: 10.1016/j.jflm.2022.102369] [Reference Citation Analysis]
11 Tadelle A. QT Interval Prolongation in Cirrhotic Cardiomyopathy. RRCC 2022;Volume 13:55-61. [DOI: 10.2147/rrcc.s371615] [Reference Citation Analysis]
12 Ridjab DA, Ivan I, Budiman F, Tenggara R. Evaluation of subclinical ventricular systolic dysfunction assessed using global longitudinal strain in liver cirrhosis: A systematic review, meta-analysis, and meta-regression. PLoS ONE 2022;17:e0269691. [DOI: 10.1371/journal.pone.0269691] [Reference Citation Analysis]
13 Vogt B, Chu AF. Cardiovascular Considerations in Patients with Liver Cirrhosis. Digestive Disease Interventions 2022;06:155-160. [DOI: 10.1055/s-0042-1745860] [Reference Citation Analysis]
14 Dangl M, Eisenberg T, Grant JK, Vincent L, Colombo R, Sancassani R, Braghiroli J, Martin P, Vianna R, Nicolau-raducu R, Mendoza C. A comprehensive review of coronary artery disease in patients with end-stage liver disease. Transplantation Reviews 2022. [DOI: 10.1016/j.trre.2022.100709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen T, Huang Z, Chen W, Ding R, Li N, Cui H, Wu F, Liang C, Cong X. Potential cardioprotective influence of bupropion against CCl4-triggered cirrhotic cardiomyopathy. Arabian Journal of Chemistry 2022;15:103599. [DOI: 10.1016/j.arabjc.2021.103599] [Reference Citation Analysis]
16 Bergasa NV. Complications of Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_15] [Reference Citation Analysis]
17 Zhang S, Zhou J, Wu W, Zhu Y, Liu X. The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications. Aging and disease 2022. [DOI: 10.14336/ad.2022.0817] [Reference Citation Analysis]
18 Bodys-Pełka A, Kusztal M, Raszeja-Wyszomirska J, Główczyńska R, Grabowski M. What's New in Cirrhotic Cardiomyopathy?-Review Article. J Pers Med 2021;11:1285. [PMID: 34945757 DOI: 10.3390/jpm11121285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kian W, Zemel M, H. Kestenbaum E, Alguayn W, Shvarts B, A. Sharb A, Levitas D, Kian Y, Peled N, Yakobson A. Cardiomyopathy Etiologies, Symptoms and Management. Cardiomyopathy - Disease of the Heart Muscle 2021. [DOI: 10.5772/intechopen.95566] [Reference Citation Analysis]
20 Desai MS. Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy. Anal Biochem 2021;:114388. [PMID: 34587512 DOI: 10.1016/j.ab.2021.114388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yazdanyar A, Lo KB, Pelayo J, Sanon J, Romero A, Quintero E, Ahluwalia A, Gupta S, Sankaranarayanan R, Mathew R, Rangaswami J. Association Between Cirrhosis and 30-Day Rehospitalization After Index Hospitalization for Heart Failure. Curr Probl Cardiol 2021;:100993. [PMID: 34571101 DOI: 10.1016/j.cpcardiol.2021.100993] [Reference Citation Analysis]
22 Mester RA, Stoll WD. Cirrhotic Cardiomyopathy and Cardiac Failure after Liver Transplantation: A Case Series. Transplant Proc 2021;53:2354-7. [PMID: 34417032 DOI: 10.1016/j.transproceed.2021.07.019] [Reference Citation Analysis]
23 Manglani R, Satija A, Srinivasan M, Epelbaum O. Not for the Faint of Heart. Ann Am Thorac Soc 2021;18:519-23. [PMID: 33646074 DOI: 10.1513/AnnalsATS.202007-817CC] [Reference Citation Analysis]
24 Shayesteh S, Guillemin GJ, Rashidian A, Faghir-Ghanesefat H, Mani AR, Tavangar SM, Dehpour AR. 1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis. Eur J Pharmacol 2021;908:174309. [PMID: 34252442 DOI: 10.1016/j.ejphar.2021.174309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kakar P, Gubitosa J, Gerula C. Echocardiography in the Liver Transplant Patient. Curr Cardiol Rep 2021;23:110. [PMID: 34216273 DOI: 10.1007/s11886-021-01531-1] [Reference Citation Analysis]
26 Sheibani M, Nezamoleslami S, Mousavi SE, Faghir-Ghanesefat H, Yousefi-Manesh H, Rezayat SM, Dehpour A. Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats. J Cardiovasc Pharmacol 2020;76:286-95. [PMID: 32902943 DOI: 10.1097/FJC.0000000000000872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Nasser I, Miranda H, Perez RM, Cabiddu R, Malosa L, Dias I, Brown A, Reis MS. Limited cardiopulmonary capacity in patients with liver cirrhosis when compared to healthy subjects. Rev Assoc Med Bras (1992) 2021;67:94-100. [PMID: 34161483 DOI: 10.1590/1806-9282.67.01.20200449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Chung HS, Woo A, Chae MS, Hong SH, Park CS, Choi JH, Jo YS. Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation. Int J Med Sci 2021;18:2500-9. [PMID: 34104081 DOI: 10.7150/ijms.54202] [Reference Citation Analysis]
29 Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased? Curr Cardiol Rev 2021;17:78-84. [PMID: 31072296 DOI: 10.2174/1573403X15666190509084519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
30 Addoumieh A, Abdallah MS, Ballout JA, Thuita L, Klein A, Jaber WA, Arsanjani R, Carey W, Majdalany D. Clinical implications of inducible left ventricular outflow tract obstruction among patients undergoing liver transplant evaluation. American Heart Journal Plus: Cardiology Research and Practice 2021;4:100026. [DOI: 10.1016/j.ahjo.2021.100026] [Reference Citation Analysis]
31 Zhang Y, Fang XM. Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine. Evid Based Complement Alternat Med 2021;2021:6655335. [PMID: 33777158 DOI: 10.1155/2021/6655335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
32 von Köckritz F, Braun A, Schmuck RB, Dobrindt EM, Eurich D, Heinzel FR, Pieske B, Escher F, Zhang K. Speckle Tracking Analysis Reveals Altered Left Atrial and Ventricular Myocardial Deformation in Patients with End-Stage Liver Disease. J Clin Med 2021;10:897. [PMID: 33668295 DOI: 10.3390/jcm10050897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Wang F, So KF, Xiao J, Wang H. Organ-organ communication: The liver's perspective. Theranostics 2021;11:3317-30. [PMID: 33537089 DOI: 10.7150/thno.55795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
34 Pabolu S, Dudekula A, Pitchumoni CS. Gastrointestinal Manifestations of Non-GI Disorders. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_86] [Reference Citation Analysis]
35 Schmeding M, Hein M. Eingriffe an der Leber. Chirurgie für Anästhesisten 2021. [DOI: 10.1007/978-3-662-53338-3_41] [Reference Citation Analysis]
36 Pabolu S, Dudekula A, Pitchumoni CS. Gastrointestinal Manifestations of Non-GI Disorders. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-319-90761-1_86-1] [Reference Citation Analysis]
37 Durst MM, Eitzen EA, Benken ST. Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis. Ann Pharmacother 2021;55:970-9. [PMID: 33327736 DOI: 10.1177/1060028020980727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zardi EM, Giorgi C, Dobrina A, Vecile E, Zardi DM. Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome. Med Res Rev 2021;41:739-53. [PMID: 33174630 DOI: 10.1002/med.21755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020; 26(37): 5561-5596 [PMID: 33088154 DOI: 10.3748/wjg.v26.i37.5561] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
40 Mousavi K, Niknahad H, Ghalamfarsa A, Mohammadi H, Azarpira N, Ommati MM, Heidari R. Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms. Clin Exp Hepatol 2020;6:207-19. [PMID: 33145427 DOI: 10.5114/ceh.2020.99513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
41 Chen JL, Chen YL, Qi B, Pan ZY, Lu YF, Zhang W, Zhu J, Yu WF, Song JC, Lu YG. Impact of Intraoperative Norepinephrine Support on Living Donor Liver Transplantation Outcomes: A Retrospective Cohort Study of 430 Children. Front Pharmacol 2020;11:1254. [PMID: 32922292 DOI: 10.3389/fphar.2020.01254] [Reference Citation Analysis]
42 Smith RE, Friedman AD, Murchison JA, Tanner SB, Smith PA, Dollar BT. Acute Life-Threatening Complications of Portal Hypertension: a Review of Pathophysiology, Incidence, Management, and Cost. SN Compr Clin Med 2020;2:1628-1645. [DOI: 10.1007/s42399-020-00435-5] [Reference Citation Analysis]
43 Sawalha K, Kadado AJ, Gupta K, Al-Akchar M, Battisha A, Abozenah M, Salerno C, Gupta M, Khan A, Islam AM. Outcomes of MitraClip Placement in Patients With Liver Cirrhosis. Cardiovasc Revasc Med 2021;29:50-3. [PMID: 32839129 DOI: 10.1016/j.carrev.2020.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Isaak A, Praktiknjo M, Jansen C, Faron A, Sprinkart AM, Pieper CC, Chang J, Fimmers R, Meyer C, Dabir D, Thomas D, Trebicka J, Attenberger U, Kuetting D, Luetkens JA. Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis. Radiology 2020;297:51-61. [PMID: 32808886 DOI: 10.1148/radiol.2020201057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
45 Yoon U, Topper J, Goldhammer J. Preoperative Evaluation and Anesthetic Management of Patients With Liver Cirrhosis Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2020:S1053-0770(20)30816-8. [PMID: 32891522 DOI: 10.1053/j.jvca.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Arya S, Deshpande H, Belwal S, Sharma P, Sadana P, Chandrakant, Rahman F, Gupta M, Uniyal B. Association between cardiac dysfunction, arrhythmias and chronic liver diseases: A narrative review. Trends in Anaesthesia and Critical Care 2020;32:4-12. [DOI: 10.1016/j.tacc.2020.03.003] [Reference Citation Analysis]
47 Kim HM, Kim HK, Lee JH, Lee YB, Park EA, Park JB, Lee SP, Kim YJ, Kim YJ, Yoon JH, Sohn DW. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson 2020;22:25. [PMID: 32321533 DOI: 10.1186/s12968-020-00622-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
48 Huelin P, Puente A, Cuadrado A, Fábrega E. Manifestaciones extrahepáticas de la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:338-345. [DOI: 10.1016/j.med.2020.04.005] [Reference Citation Analysis]
49 Giannelli V, Roux O, Laouénan C, Manchon P, Ausloos F, Bachelet D, Rautou PE, Weiss E, Moreau R, Mebazaa A, Cohen-Solal A, Durand F, Francoz C. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. J Hepatol 2020;72:463-71. [PMID: 31622697 DOI: 10.1016/j.jhep.2019.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
50 Toma L, Stanciu AM, Zgura A, Bacalbasa N, Diaconu C, Iliescu L. Electrocardiographic Changes in Liver Cirrhosis-Clues for Cirrhotic Cardiomyopathy. Medicina (Kaunas) 2020;56:E68. [PMID: 32050594 DOI: 10.3390/medicina56020068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ibrahim MG, Sharafeldin AA, Mousa NI, Mousa TK, El Missiri AM. Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection. Egypt Heart J 2020;72:7. [PMID: 32030482 DOI: 10.1186/s43044-020-0042-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Sandal S, Chen T, Cantarovich M. The Challenges With the Cardiac Evaluation of Liver and Kidney Transplant Candidates. Transplantation 2020;104:251-8. [DOI: 10.1097/tp.0000000000002951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
53 Nasser I, Perez RM, Reis MS, Dias I, Willardson JM, Miranda H. Cardiovascular Acute Effects of Traditional vs. Paired Set Resistance Training in Patients With Liver Cirrhosis. Res Q Exerc Sport 2020;91:630-9. [PMID: 31999503 DOI: 10.1080/02701367.2019.1696013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Dercle L, Ma J, Xie C, Chen AP, Wang D, Luk L, Revel-Mouroz P, Otal P, Peron JM, Rousseau H, Lu L, Schwartz LH, Mokrane FZ, Zhao B. Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine. Eur J Radiol 2020;125:108850. [PMID: 32070870 DOI: 10.1016/j.ejrad.2020.108850] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
55 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
56 Garcia-martinez R, Diaz-ruiz R, Millan J, Bañares R. Chronic Liver Failure and Acute-on-Chronic Liver Failure. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_33] [Reference Citation Analysis]
57 Arya S, Kumar P, Tiwari B, Belwal S, Saxena S, Abbas H. What Every Intensivist should Know about Impairment of Cardiac Function and Arrhythmias in Liver Disease Patients: A Review. Indian J Crit Care Med 2020;24:1251-5. [PMID: 33446981 DOI: 10.5005/jp-journals-10071-23695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vasavan T, Williamson C. Sex and cardiac electrophysiology. Sex and Cardiac Electrophysiology 2020. [DOI: 10.1016/b978-0-12-817728-0.00065-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Porter T, Shillcutt S, Adams M, Desjardins G, Glas K, Olson J, Troughton R. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: A report from the american society of echocardiography. J Indian Acad Echocardiogr Cardiovasc Imaging 2020;4:122. [DOI: 10.4103/2543-1463.282192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Abuelkasem E, Wang DW, Omer MA, Abdelmoneim SS, Howard-quijano K, Rakesh H, Subramaniam K. Perioperative clinical utility of myocardial deformation imaging: a narrative review. British Journal of Anaesthesia 2019;123:408-20. [DOI: 10.1016/j.bja.2019.04.065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
61 Kovalic AJ, Cholankeril G, Satapathy SK. Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. Transl Gastroenterol Hepatol. 2019;4:65. [PMID: 31620647 DOI: 10.21037/tgh.2019.08.09] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
62 Vora RS, Subramanian RM. Hypotension in Cirrhosis. Clin Liver Dis (Hoboken) 2019;13:149-53. [PMID: 31316760 DOI: 10.1002/cld.764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Adejumo AC, Adejumo KL, Akanbi O, Adegbala OM, Alayo QA, Fijabi DO, Ogundipe OA, Almaddah N, Pani L, Adeboye A. Predictors, burden and impact of cardiac arrhythmias among patients hospitalized with end-stage liver disease. Heart Lung 2020;49:73-9. [PMID: 31320178 DOI: 10.1016/j.hrtlng.2019.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Sakr AE, Fraser GE, Doctorian TP, Kim HB, Narasimha D, Abudayyeh I, Hilliard AD, Shih W, de Vera ME, Baron PW, Volk ML, Stoletniy LN. Predictors of Systolic Heart Failure and Mortality Following Orthotopic Liver Transplantation: a Single-Center Cohort. Transplantation Proceedings 2019;51:1950-5. [DOI: 10.1016/j.transproceed.2019.04.063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
65 Couperus L, Vliegen H, Sorgdrager B, den Dulk A, Beeres S, Sarton E, Dubbeld J, Schalij M, Jukema J, van Hoek B, Scherptong R. Prognostic Importance of Increased Right Ventricular Afterload in Orthotopic Liver Transplantation Recipients With Endstage Cirrhosis. Heart, Lung and Circulation 2019;28:893-900. [DOI: 10.1016/j.hlc.2018.04.290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 A. Vitin A, Tomescu D, Azamfirei L. Nonischemic Cardiomyopathy in Liver Transplant Recipients. Liver Cirrhosis - Debates and Current Challenges 2019. [DOI: 10.5772/intechopen.83394] [Reference Citation Analysis]
67 Mihailovici AR, Donoiu I, Gheonea DI, Mirea O, Târtea GC, Buşe M, Calborean V, Obleagă C, Pădureanu V, Istrătoaie O. NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis - Correlations with Disease Severity. Med Princ Pract 2019. [PMID: 30995644 DOI: 10.1159/000499930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
68 Huang CH, Wu LS, Jeng WJ, Cheng YF, Ko YS, Sheen IS, Lin CY. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival. PLoS One 2019;14:e0212770. [PMID: 30889181 DOI: 10.1371/journal.pone.0212770] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Braz J Med Biol Res 2019;52:e7809. [PMID: 30785477 DOI: 10.1590/1414-431X20187809] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
70 Moon YJ, Kim JW, Bang YS, Lim YS, Ki Y, Sang BH. Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment. PLoS One 2019;14:e0209100. [PMID: 30682022 DOI: 10.1371/journal.pone.0209100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
71 Wray C, Findlay JY. Cardiac Evaluation and Management. Critical Care for Potential Liver Transplant Candidates 2019. [DOI: 10.1007/978-3-319-92934-7_1] [Reference Citation Analysis]
72 Sharma S, Prasad A, Karamchandani K. Extracorporeal Membrane Oxygenation in a Patient With Cirrhotic Cardiomyopathy: A Case Report. Journal of Cardiothoracic and Vascular Anesthesia 2019;33:173-5. [DOI: 10.1053/j.jvca.2018.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Lee YB, Lee JH. Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients. Clin Mol Hepatol 2018;24:372-3. [PMID: 30531663 DOI: 10.3350/cmh.2018.0098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Yap EML, Supe MGS, Yu II. Cardiac Profile of Filipino Patients With Liver Cirrhosis: A 10-Year Study. Cardiol Res 2018;9:358-63. [PMID: 30627286 DOI: 10.14740/cr804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Dercle L, Billey C, Cognet T, Cassol E, Sinigaglia M, Pascal P, Berry I, Otal P, Bureau C, Lairez O. Spleno-hepatic index to predict portal hypertension by equilibrium radionuclide ventriculography. Nucl Med Commun 2018;39:1138-42. [PMID: 30371604 DOI: 10.1097/MNM.0000000000000927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Eyvazian VA, Gordin JS, Yang EH, Aksoy O, Honda HM, Busuttil RW, Agopian VG, Vorobiof G. Incidence, Predictors, and Outcomes of New-Onset Left Ventricular Systolic Dysfunction After Orthotopic Liver Transplantation. J Card Fail 2019;25:166-72. [PMID: 30412734 DOI: 10.1016/j.cardfail.2018.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
77 Hulo S, Edme JL, Inamo J, Van Bulck R, Dharancy S, Neviere R. Elevated alveolar nitric oxide is linked to poor aerobic capacity and chronotropic incompetence in liver transplant candidates. J Breath Res 2018;12:046008. [PMID: 30080156 DOI: 10.1088/1752-7163/aad847] [Reference Citation Analysis]
78 Scholte NTB, Lenzen MJ, van der Hoven B, Rietdijk WJR, Metselaar HJ, den Uil CA. In-hospital cardiovascular events after liver transplantation: predictors and long-term outcome. Neth Heart J 2018;26:506-11. [PMID: 30091113 DOI: 10.1007/s12471-018-1144-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
79 Sharma S, Karamchandani K, Wilson R, Baskin S, Bezinover D. Acute heart failure after Orthotopic liver transplantation: a case series from one center. BMC Anesthesiol 2018;18:102. [PMID: 30064379 DOI: 10.1186/s12871-018-0560-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
80 Flaherty D, Kim S, Zerillo J, Park C, Joseph T, Hill B, Lin HM, Li J, Hamsher C, Weiner MM, DeMaria S Jr. Preoperative QTc Interval is Not Associated With Intraoperative Cardiac Events or Mortality in Liver Transplantation Patients. J Cardiothorac Vasc Anesth 2019;33:961-6. [PMID: 30097315 DOI: 10.1053/j.jvca.2018.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
81 Scarpati G, De Robertis E, Esposito C, Piazza O. Hepatic encephalopathy and cirrhotic cardiomyopathy in Intensive Care Unit. Minerva Anestesiol 2018;84. [DOI: 10.23736/s0375-9393.18.12343-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Vetrugno L, Barnariol F, Bignami E, Centonze GD, De Flaviis A, Piccioni F, Auci E, Bove T. Transesophageal ultrasonography during orthotopic liver transplantation: Show me more. Echocardiography 2018;35:1204-15. [PMID: 29858886 DOI: 10.1111/echo.14037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
83 Vetrugno L, Bignami E, Barbariol F, Langiano N, De Lorenzo F, Matellon C, Menegoz G, Della Rocca G. Cardiac output measurement in liver transplantation patients using pulmonary and transpulmonary thermodilution: a comparative study. J Clin Monit Comput 2019;33:223-31. [PMID: 29725794 DOI: 10.1007/s10877-018-0149-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
84 Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik J, Williamson C. Heart and bile acids - Clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis 2018;1864:1345-55. [PMID: 29317337 DOI: 10.1016/j.bbadis.2017.12.039] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 11.5] [Reference Citation Analysis]
85 Rimbaş RC, Baldea SM, Guerra RDGA, Visoiu SI, Rimbaş M, Pop CS, Vinereanu D. New Definition Criteria of Myocardial Dysfunction in Patients with Liver Cirrhosis: A Speckle Tracking and Tissue Doppler Imaging Study. Ultrasound Med Biol 2018;44:562-74. [PMID: 29306590 DOI: 10.1016/j.ultrasmedbio.2017.11.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
86 Heintz K, Hollenberg SM. Circulatory Physiology in Liver Disease. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_2] [Reference Citation Analysis]
87 Shah J, Shao E. Cardiohepatic Interactions. Encyclopedia of Cardiovascular Research and Medicine 2018. [DOI: 10.1016/b978-0-12-809657-4.11046-4] [Reference Citation Analysis]
88 Droc G, Scărlătescu E. Right Heart Dysfunction in Liver Transplantation. Right Heart Pathology 2018. [DOI: 10.1007/978-3-319-73764-5_50] [Reference Citation Analysis]
89 Shao E. OBSOLETE: Cardiohepatic Interactions. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.11046-3] [Reference Citation Analysis]
90 Hastie J, Moitra VK. Routine Postoperative Care After Liver Transplantation. Liver Anesthesiology and Critical Care Medicine 2018. [DOI: 10.1007/978-3-319-64298-7_31] [Reference Citation Analysis]
91 Nevah MI, Kuruvilla AC, Fallon MB. Cardiopulmonary Complications of Cirrhosis. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00018-5] [Reference Citation Analysis]
92 Singh S, Hollenberg SM. Cardiovascular Alterations in Acute and Chronic Liver Failure. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_9] [Reference Citation Analysis]
93 Mocarzel LOC, Rossi MM, Miliosse BM, Lanzieri PG, Gismondi RA. Cirrhotic Cardiomyopathy: A New Clinical Phenotype. Arq Bras Cardiol 2017;108:564-8. [PMID: 28699978 DOI: 10.5935/abc.20170066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
94 Farouk H, Al-maimoony T, Nasr A, El-serafy M, Ghany MA. Echocardiographic assessment of the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis. Cor Vasa 2017;59:e540-5. [DOI: 10.1016/j.crvasa.2016.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Ridha A, Al-Abboodi Y, Fasullo M. The Outcome of Thoracentesis versus Chest Tube Placement for Hepatic Hydrothorax in Patients with Cirrhosis: A Nationwide Analysis of the National Inpatient Sample. Gastroenterol Res Pract 2017;2017:5872068. [PMID: 29317865 DOI: 10.1155/2017/5872068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
96 Kamath PS, Keegan MT. Preoperative Evaluation of the Patient with Liver Disease. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch11] [Reference Citation Analysis]
97 Horvatits T, Drolz A, Rutter K, Roedl K, Kluge S, Fuhrmann V. Hepatokardiale Wechselwirkungen. Wien klin Mag 2017;20:130-135. [DOI: 10.1007/s00740-017-0183-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Adelmann D, Kronish K, Ramsay MA. Anesthesia for Liver Transplantation. Anesthesiology Clinics 2017;35:491-508. [DOI: 10.1016/j.anclin.2017.04.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
99 Sang B, Kim J, Yoo J, Bang Y, Choi YS, Moon Y, Hwang GS, Lim YS. Pretransplant diastolic wall strain assessed by transthoracic echocardiography and its implication on posttransplant survival rate in liver transplantation. Anesth Pain Med 2017;12:159-164. [DOI: 10.17085/apm.2017.12.2.159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
100 Taura P, Martinez-Palli G, Blasi A, Rivas E, Beltran J, Balust J. Intraoperative Management of High-Risk Liver Transplant Recipients: Concerns and Challenges. Transplant Proc 2016;48:2491-4. [PMID: 27742332 DOI: 10.1016/j.transproceed.2016.08.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
101 Zhao J, Li S, Ren L, Guo X, Qi X. Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis. Am J Med Sci 2017;354:131-9. [PMID: 28864370 DOI: 10.1016/j.amjms.2017.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
102 Baibhav B, Mahabir CA, Xie F, Shostrom VK, McCashland TM, Porter TR. Predictive Value of Dobutamine Stress Perfusion Echocardiography in Contemporary End-Stage Liver Disease. J Am Heart Assoc 2017;6:e005102. [PMID: 28219921 DOI: 10.1161/JAHA.116.005102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
103 Ramsay M. Portopulmonary Hypertension and Hepatopulmonary Syndrome. Anesthesia and Perioperative Care for Organ Transplantation 2017. [DOI: 10.1007/978-1-4939-6377-5_33] [Reference Citation Analysis]
104 Zardi EM, Zardi DM, Dobrina A, Abbate A. Cirrhotic Cardiomyopathy and Liver Transplantation. Anesthesia and Perioperative Care for Organ Transplantation 2017. [DOI: 10.1007/978-1-4939-6377-5_35] [Reference Citation Analysis]
105 Gajanana D, Gupta S, Koshkelashvili N, Rubio M, Bhalla V, Amanullah A. Electrocardiographic and echocardiographic changes in patients undergoing liver transplant stratified by outcomes. Int J Cardiol 2016;223:699-700. [PMID: 27568992 DOI: 10.1016/j.ijcard.2016.08.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Neviere R, Trinh-Duc P, Hulo S, Edme JL, Dehon A, Boleslawski E, Dharancy S, Lebuffe G. Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantation. Transpl Int 2016;29:1307-16. [PMID: 27649520 DOI: 10.1111/tri.12861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
107 Licata A, Novo G, Colomba D, Tuttolomondo A, Galia M, Camma' C. Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown). 2016;17:26-36. [PMID: 26065511 DOI: 10.2459/JCM.0000000000000288] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
108 Gerardin J, Rodriguez F, Saraf A, Book WM. Heart transplantation in adults for Fontan failure. Progress in Pediatric Cardiology 2016;42:17-22. [DOI: 10.1016/j.ppedcard.2016.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Shih PY, Lin WY, Hung MH, Cheng YJ, Chan KC. Evaluation of cardiac output by bioreactance technique in patients undergoing liver transplantation. Acta Anaesthesiol Taiwan 2016;54:57-61. [PMID: 27461188 DOI: 10.1016/j.aat.2016.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
110 Zhao J, Qi X, Hou F, Ning Z, Zhang X, Deng H, Peng Y, Li J, Wang X, Li H, Guo X. Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis. Am J Med Sci 2016;352:285-95. [PMID: 27650234 DOI: 10.1016/j.amjms.2016.06.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
111 Nath Dubey T, Panjwani R. STUDY OF CARDIAC STATUS IN END STAGE CHRONIC LIVER DISEASE AND ITS CORRELATION WITH MELD. jemds 2016;5:3026-3029. [DOI: 10.14260/jemds/2016/704] [Reference Citation Analysis]
112 Parker MW, Aurigemma GP. Cardiac Structure and Function in Hyperaldosteronism. Circ: Cardiovascular Imaging 2016;9. [DOI: 10.1161/circimaging.116.005064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Saeedi Saravi SS, Ghazi-Khansari M, Ejtemaei Mehr S, Nobakht M, Mousavi SE, Dehpour AR. Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy. World J Gastroenterol 2016; 22(19): 4685-4694 [PMID: 27217700 DOI: 10.3748/wjg.v22.i19.4685] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
114 Díaz Fontenla F, Salcedo Plaza M, Bañares Cañizares R, Clemente Ricote G. Manifestaciones extradigestivas de la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:627-634. [DOI: 10.1016/j.med.2016.05.013] [Reference Citation Analysis]
115 Krowka MJ. Cardiopulmonary examination. Clin Liver Dis (Hoboken) 2016;7:116-8. [PMID: 31041044 DOI: 10.1002/cld.550] [Reference Citation Analysis]
116 Sundaram V, Fang JC. Gastrointestinal and Liver Issues in Heart Failure. Circulation 2016;133:1696-703. [DOI: 10.1161/circulationaha.115.020894] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 14.8] [Reference Citation Analysis]
117 Lopez-Delgado JC, Ballus J, Esteve F, Betancur-Zambrano NL, Corral-Velez V, Mañez R, Betbese AJ, Roncal JA, Javierre C. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol 2016; 22(9): 2657-2667 [PMID: 26973406 DOI: 10.3748/wjg.v22.i9.2657] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
118 Wong F. Cardiac changes in pediatric liver transplant recipients: are they truly irreversible? Hepatol Int 2016;10:390-3. [PMID: 26884376 DOI: 10.1007/s12072-016-9708-7] [Reference Citation Analysis]
119 Naqvi IH, Mahmood K, Naeem M, Vashwani AS, Ziaullah S. The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease. Prz Gastroenterol 2016;11:247-56. [PMID: 28053679 DOI: 10.5114/pg.2016.57962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
120 Milić S, Lulić D, Štimac D, Ružić A, Zaputović L. Cardiac manifestations in alcoholic liver disease. Postgrad Med J 2016;92:235-9. [PMID: 26850503 DOI: 10.1136/postgradmedj-2015-133755] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
121 Barbosa M, Guardado J, Marinho C, Rosa B, Quelhas I, Lourenço A, Cotter J. Cirrhotic cardiomyopathy: Isn’t stress evaluation always required for the diagnosis? World J Hepatol 2016; 8(3): 200-206 [PMID: 26839643 DOI: 10.4254/wjh.v8.i3.200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
122 Sampaio F, Pimenta J. Left ventricular function assessment in cirrhosis: Current methods and future directions. World J Gastroenterol 2016; 22(1): 112-125 [PMID: 26755864 DOI: 10.3748/wjg.v22.i1.112] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
123 Shillcutt SK, Ringenberg KJ, Chacon MM, Brakke TR, Montzingo CR, Lyden ER, Schulte TE, Porter TR, Lisco SJ. Liver Transplantation: Intraoperative Transesophageal Echocardiography Findings and Relationship to Major Postoperative Adverse Cardiac Events. Journal of Cardiothoracic and Vascular Anesthesia 2016;30:107-14. [DOI: 10.1053/j.jvca.2015.09.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
124 Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options. Semin Intervent Radiol. 2015;32:445-454. [PMID: 26622108 DOI: 10.1055/s-0035-1564794] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
125 Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol 2015; 21(41): 11502-11521 [PMID: 26556983 DOI: 10.3748/wjg.v21.i41.11502] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 95] [Article Influence: 13.1] [Reference Citation Analysis]
126 Barakat AA, Metwaly AA, Nasr FM, El-Ghannam M, El-Talkawy MD, Taleb HA. Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis. Electron Physician 2015;7:1349-58. [PMID: 26516441 DOI: 10.14661/1349] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
127 Khemakanok K, Khositseth A, Treepongkaruna S, Teeraratkul S, Pansrimangkorn W, Leelaudomlipi S, Bunmee U, Sriphojanart S. Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int 2016;10:518-24. [DOI: 10.1007/s12072-015-9674-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
128 Porter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, Troughton RW. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015;28:40-56. [PMID: 25559474 DOI: 10.1016/j.echo.2014.09.009] [Cited by in Crossref: 264] [Cited by in F6Publishing: 278] [Article Influence: 37.7] [Reference Citation Analysis]
129 Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int 2014;8:308-15. [PMID: 25221635 DOI: 10.1007/s12072-014-9531-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 8.3] [Reference Citation Analysis]
130 Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014;8:308-315. [PMID: 25221635 DOI: 10.1007/s12072-014-9531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 de Lima DC, Ribeiro HS, Cristina R, Oliveira M, de Vasconcelos Generoso S, Lima AS, Toulson Davisson Correia MI. Functional status and heart rate variability in end-stage liver disease patients: Association with nutritional status. Nutrition 2015;31:971-4. [DOI: 10.1016/j.nut.2015.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
132 Horvatits T, Drolz A, Rutter K, Roedl K, Kluge S, Fuhrmann V. [Hepatocardiac disorders : Interactions between two organ systems]. Med Klin Intensivmed Notfmed 2016;111:447-52. [PMID: 26070920 DOI: 10.1007/s00063-015-0043-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Zardi EM, Zardi DM, Chin D, Sonnino C, Dobrina A, Abbate A. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase. J Cardiol 2016;67:125-30. [PMID: 26074443 DOI: 10.1016/j.jjcc.2015.04.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
134 Lopez-Delgado JC, Esteve F, Javierre C, Ventura JL, Mañez R, Farrero E, Torrado H, Rodríguez-Castro D, Carrio ML. Influence of cirrhosis in cardiac surgery outcomes. World J Hepatol 2015; 7(5): 753-760 [PMID: 25914775 DOI: 10.4254/wjh.v7.i5.753] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
135 Mozos I. Arrhythmia risk in liver cirrhosis. World J Hepatol 2015; 7(4): 662-672 [PMID: 25866603 DOI: 10.4254/wjh.v7.i4.662] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
136 Silvestre OM, Bacal F, Ximenes RO, Carrilho FJ, D'Albuquerque LA, Farias AQ. Cardiohepatic interactions--from humoral theory to organ transplantation. Arq Bras Cardiol 2014;102:e65-7. [PMID: 25004427 DOI: 10.5935/abc.20140079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
137 Tuttolomondo A, Buttà C, Casuccio A, Di Raimondo D, Serio A, D'Aguanno G, Pecoraro R, Renda C, Giarrusso L, Miceli G, Cirrincione A, Pinto A. QT Indexes in Cirrhotic Patients: Relationship with Clinical Variables and Potential Diagnostic Predictive Value. Arch Med Res 2015;46:207-13. [PMID: 25843561 DOI: 10.1016/j.arcmed.2015.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
138 Mocarzel L, Lanzieri P, Nascimento J, Peixoto C, Ribeiro M, Mesquita E. Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review. Case Reports Hepatol. 2015;2015:573513. [PMID: 25874140 DOI: 10.1155/2015/573513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
139 Farr M, Schulze PC. Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies. Clin Med Insights Cardiol 2014;8:67-74. [PMID: 25657603 DOI: 10.4137/CMC.S15722] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
140 Steadman RH, Ramsay MA. Portopulmonary Hypertension and Hepatopulmonary Syndrome. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00039-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Kittleson MM. Pretransplantation Evaluation. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00031-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Escobar B, Taurá P, Martínez-Palli G, Fondevila C, Balust J, Beltrán J, Fernández J, García-Pagán JC, García-Valdecasas JC. Stroke volume response to liver graft reperfusion stress in cirrhotic patients. World J Surg. 2014;38:927-935. [PMID: 24132825 DOI: 10.1007/s00268-013-2289-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
143 Baskar S, George PL, Eghtesad B, Radhakrishnan K, Hupertz V, Aziz PF, Alkhouri N. Cardiovascular risk factors and cardiac disorders in long-term survivors of pediatric liver transplantation. Pediatr Transplantation 2015;19:48-55. [DOI: 10.1111/petr.12388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
144 Coverstone E, Korenblat K, Crippin JS, Chapman WC, Kates AM, Zajarias A. Aortic balloon valvuloplasty prior to orthotopic liver transplantation: a novel approach to aortic stenosis and end-stage liver disease. Case Rep Cardiol 2014;2014:325136. [PMID: 25431682 DOI: 10.1155/2014/325136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
145 Licata A, Mazzola A, Ingrassia D, Calvaruso V, Cammà C, Craxì A. Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med. 2014;25:795-802. [PMID: 25245607 DOI: 10.1016/j.ejim.2014.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
146 Somani PO, Contractor Q, Chaurasia AS, Rathi PM. Diastolic dysfunction characterizes cirrhotic cardiomyopathy. Indian Heart J. 2014;66:649-655. [PMID: 25634400 DOI: 10.1016/j.ihj.2014.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
147 Yang CH, Ting WJ, Day CH, Ju DT, Yeh YL, Chung LC, Tsai FJ, Tsai CH, Tsai Y, Huang CY. SHSST cyclodextrin complex prevents the fibrosis effect on CCl4-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects. Int J Mol Sci. 2014;15:8037-8048. [PMID: 24815066 DOI: 10.3390/ijms15058037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
148 Lee CM, Lee YT, Jeng LB, Chang CY, Wei J. Monotherapy with tacrolimus for heart and liver transplant: a case report. Transplant Proc 2014;46:980-1. [PMID: 24767396 DOI: 10.1016/j.transproceed.2013.11.101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Moaref A, Zamirian M, Yazdani M, Salehi O, Sayadi M, Aghasadeghi K. The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients. Int Cardiovasc Res J 2014;8:39-43. [PMID: 24936479] [Reference Citation Analysis]
150 Huh IY, Park ES, Kim KI, Lee AR, Hwang GS. Alteration of the QT variability index in end-stage liver disease. Korean J Anesthesiol 2014;66:199-203. [PMID: 24729841 DOI: 10.4097/kjae.2014.66.3.199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
151 Farias AQ, Silvestre OM, Garcia-Tsao G, da Costa Seguro LF, de Campos Mazo DF, Bacal F, Andrade JL, Gonçalves LL, Strunz C, Ramos DS, Polli D, Pugliese V, Rodrigues AC, Furtado MS, Carrilho FJ, D'Albuquerque LA. Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology 2014;59:1043-51. [PMID: 23907731 DOI: 10.1002/hep.26643] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
152 Mori M, Aguirre AJ, Elder RW, Kashkouli A, Farris AB, Ford RM, Book WM. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol 2014;35:569-79. [PMID: 24531876 DOI: 10.1007/s00246-014-0881-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
153 Kiamanesh D, Rumley J, Moitra VK. Monitoring and managing hepatic disease in anaesthesia. Br J Anaesth. 2013;111 Suppl 1:i50-i61. [PMID: 24335399 DOI: 10.1093/bja/aet378] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
154 Ramsay M. Anesthesia for Liver Transplantation. Transplantation of the Liver 2014. [DOI: 10.1016/b978-1-4557-0268-8.00046-4] [Reference Citation Analysis]
155 Darstein F, König C, Hoppe-Lotichius M, Grimm D, Knapstein J, Mittler J, Zimmermann A, Otto G, Lang H, Galle PR. Preoperative left ventricular hypertrophy is associated with reduced patient survival after liver transplantation. Clin Transplant. 2014;28:236-242. [PMID: 24372847 DOI: 10.1111/ctr.12304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
156 Reddy ST, Thai NL, Fakhri AA, Oliva J, Tom KB, Dishart MK, Doyle M, Yamrozik JA, Williams RB, Grant SB, Poydence J, Shah M, Singh A, Nathan S, Biederman RW. Exploratory Use of Cardiovascular Magnetic Resonance Imaging in Liver Transplantation: A One-Stop Shop for Preoperative Cardiohepatic Evaluation. Transplantation 2013;96:827-33. [DOI: 10.1097/tp.0b013e3182a078e9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
157 Roumeliotis N, Hosking M, Guttman O. Celiac disease and cardiomyopathy in an adolescent with occult cirrhosis. Paediatr Child Health. 2012;17:437-439. [PMID: 24082804 DOI: 10.1093/pch/17.8.437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
158 Pellicori P, Torromeo C, Calicchia A, Ruffa A, Di Iorio M, Cleland JG, Merli M. Does cirrhotic cardiomyopathy exist? 50 years of uncertainty. Clin Res Cardiol. 2013;102:859-864. [PMID: 23995321 DOI: 10.1007/s00392-013-0610-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
159 Desai MS, Penny DJ. Bile acids induce arrhythmias: old metabolite, new tricks. Heart 2013;99:1629-30. [PMID: 23969477 DOI: 10.1136/heartjnl-2013-304546] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
160 Tata S, Bag R, Subramanian R, Nilles K, Pastan S. Transplantation medicine. Medical Management of the Surgical Patient 2013. [DOI: 10.1017/cbo9780511920660.045] [Reference Citation Analysis]
161 Licata A, Corrao S, Petta S, Genco C, Cardillo M, Calvaruso V, Cabibbo G, Massenti F, Cammà C, Licata G, Craxì A. NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. PLoS One 2013;8:e68364. [PMID: 23940514 DOI: 10.1371/journal.pone.0068364] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
162 Pudil R, Pelouch R, Praus R, Vašatová M, Hůlek P. Heart failure in patients with liver cirrhosis. Cor Vasa 2013;55:e391-6. [DOI: 10.1016/j.crvasa.2013.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
163 Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, Mahle WT, Kogon BE, Sahu A, Jokhadar M, McConnell ME, Book WM. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol 2013;168:3764-9. [PMID: 23849105 DOI: 10.1016/j.ijcard.2013.06.008] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 12.6] [Reference Citation Analysis]
164 Garg A, Armstrong WF. Echocardiography in liver transplant candidates. JACC Cardiovasc Imaging. 2013;6:105-119. [PMID: 23328568 DOI: 10.1016/j.jcmg.2012.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
165 Enache I, Oswald-Mammosser M, Woehl-Jaegle ML, Habersetzer F, Di Marco P, Charloux A, Doutreleau S. Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients. Respir Med. 2013;107:1030-1036. [PMID: 23615223 DOI: 10.1016/j.rmed.2013.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
166 Triposkiadis F, Starling RC, Boudoulas H, Giamouzis G, Butler J. The cardiorenal syndrome in heart failure: cardiac?Heart Fail Rev. 2012;17:355-366. [PMID: 22086438 DOI: 10.1007/s10741-011-9291-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
167 Ali A, Bhardwaj HL, Heuman DM, Jovin IS. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transplant 2013;27:E207-15. [DOI: 10.1111/ctr.12113] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
168 Belay T, Gress T, Sayyed R. Cirrhotic cardiomyopathy among patients with liver cirrhosis. OJGas 2013;03:344-348. [DOI: 10.4236/ojgas.2013.38060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
169 Dowsley TF, Bayne DB, Langnas AN, Dumitru I, Windle JR, Porter TR, Raichlin E. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation. 2012;94:646-651. [PMID: 22918216 DOI: 10.1097/tp.0b013e31825f0f97] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
170 Nandhakumar A, McCluskey SA, Srinivas C, Chandy TT. Liver transplantation: Advances and perioperative care. Indian J Anaesth 2012;56:326-35. [PMID: 23087453 DOI: 10.4103/0019-5049.100812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
171 Tachotti Pires L, Cardoso Curiati M, Vissoci Reiche F, Silvestre O, Mangini S, Carballo Afonso R, Ferraz-neto B, Bacal F. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy) After Liver Transplantation—Report of Two Cases. Transplantation Proceedings 2012;44:2497-500. [DOI: 10.1016/j.transproceed.2012.07.037] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
172 Merli M, Calicchia A, Ruffa A, Pellicori P, Riggio O, Giusto M, Gaudio C, Torromeo C. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013;24:172-176. [PMID: 22958907 DOI: 10.1016/j.ejim.2012.08.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
173 McCabe N, Farris AB, Hon H, Ford R, Book WM. Hepatocellular carcinoma in an adult with repaired tetralogy of fallot. Congenit Heart Dis 2013;8:E139-44. [PMID: 22897884 DOI: 10.1111/j.1747-0803.2012.00700.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
174 Owens AT, Jessup M. The Year in Heart Failure. Journal of the American College of Cardiology 2012;60:359-68. [DOI: 10.1016/j.jacc.2012.01.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
175 Tarquini R, Mazzoccoli G, Fusi F, Laffi G, Gensini GF, Romano SM. Non invasive continuous hemodynamic evaluation of cirrhotic patients after postural challenge. World J Hepatol 2012; 4(4): 149-153 [PMID: 22567187 DOI: 10.4254/wjh.v4.i4.149] [Reference Citation Analysis]
176 Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012;38:950-8. [PMID: 22527060 DOI: 10.1007/s00134-012-2531-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012;38:950-8. [PMID: 22527060 DOI: 10.1007/s00134-012-2531-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 155] [Article Influence: 14.1] [Reference Citation Analysis]
178 Aller MA, Heras N, Blanco-Rivero J, Arias JI, Lahera V, Balfagón G, Arias J. Portal hypertensive cardiovascular pathology: the rescue of ancestral survival mechanisms? Clin Res Hepatol Gastroenterol 2012;36:35-46. [PMID: 22264837 DOI: 10.1016/j.clinre.2011.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
179 Hastie J, Moitra VK. Routine Postoperative Care After Liver Transplantation. Liver Anesthesiology and Critical Care Medicine 2012. [DOI: 10.1007/978-1-4614-5167-9_29] [Reference Citation Analysis]
180 Sanyal AJ, Boyer TD. Renal Failure in Cirrhosis, Hepatorenal Syndrome, and Hyponatremia. Zakim and Boyer's Hepatology 2012. [DOI: 10.1016/b978-1-4377-0881-3.00021-8] [Reference Citation Analysis]
181 Garcia-tsao G. Cirrhosis and Its Sequelae. Goldman's Cecil Medicine. Elsevier; 2012. pp. 999-1007. [DOI: 10.1016/b978-1-4377-1604-7.00156-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Harinstein ME, Raval Z, Gheorghiade M, Flaherty JD. Reply. Journal of the American College of Cardiology 2011;58:2701. [DOI: 10.1016/j.jacc.2011.09.029] [Reference Citation Analysis]
183 Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ. A perspective on cirrhotic cardiomyopathy. Transplant Proc. 2011;43:1649-1653. [PMID: 21693251 DOI: 10.1016/j.transproceed.2011.01.188] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
184 Desai MS, Zainuer S, Kennedy C, Kearney D, Goss J, Karpen SJ. Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation. Gastroenterology 2011;141:1264-72, 1272.e1-4. [PMID: 21762660 DOI: 10.1053/j.gastro.2011.06.082] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
185 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
186 Aljaroudi W, Aggarwal H, Iqbal F, Heo J, Iskandrian AE. Left ventricular dyssynchrony in patients with end-stage liver disease. J Nucl Cardiol 2011;18:451-5. [DOI: 10.1007/s12350-010-9332-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
187 Logeart D, Mouquet F, Cohen-solal A, Assyag P, Pathak A, Obreja RPD. Insuffisance cardiaque et cardiomyopathies. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2011;2011:S15-S19. [DOI: 10.1016/s1261-694x(11)70005-0] [Reference Citation Analysis]